MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Free water imaging of the cholinergic forebrain in body vs. brain-first Parkinson’s disease subtypes

    S. Roytman, Y. Ota, T. Brown, P. Scott, R. Albin, P. Kanel, N. Bohnen (Ann Arbor, USA)

    Objective: To investigate the relationship between basal forebrain (BF) neurodegeneration and cholinergic system in body vs brain-first Parkinson’s disease (PD) subtypes. Background: Free water imaging…
  • 2023 International Congress

    Representation of movement repertoire in subthalamic neural circuits using a markerless 3D behavioral tracking system.

    JH. Shin, HY. Jeon, B. Jin, SM. Lee, JH. Kim, JS. Yook, JH. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: This study aimed to investigate the spatiotemporal encoding of neurons in the subthalamic nucleus using a mouse model. Background: The subthalamic nucleus is a…
  • 2023 International Congress

    Subacute parkinsonism associated with Zic4 antibodies: a case report

    V. Mendes Ferreira, M. Magriço, D. Krupka, B. Meira (Lisboa, Portugal)

    Objective: Describe a case of subacute parkinsonism associated with isolated Zic4 antibodies. Background: Movement disorders are a common feature in autoimmune encephalitis and its presentation…
  • 2023 International Congress

    Loneliness, Self-Efficacy, and Resilience: Neglected Modifiable Contributors to Parkinson’s Disease Symptom Severity and Quality of Life

    I. Subramanian, B. Mcdaniels, D. Fox, L. Mischley (Los Angeles, USA)

    Objective: To evaluate the degree to which modifiable psychosocial (PS) variables including loneliness, self-efficacy (SE) and resilience explain the variance observed in Parkinson’s disease (PD)…
  • 2023 International Congress

    Implementation and effects of telehealth exercise therapy on satisfaction and Mobility In persons with Parkinson’s.

    F. Yadolahi, N. Hosseini (tehran, Islamic Republic of Iran)

    Objective: To improve PD care and motor performance using telehealth exercise therapy in individuals with PD. Background: Parkinson’s disease (PD) is a chronic disease  with…
  • 2023 International Congress

    Association between type 2 diabetes mellitus with parkinson’s disease and the increase of the severity of depression and anxiety in a mexican population

    AA. Herrera Ruiz, DR. Aguila Godinez, AJ. Hernández-Medrano, MA. Ruiz Mafud, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To compare the severity of depression and anxiety in PwP between those with T2D and those without T2D. Background: Parkinson's disease (PD) is the…
  • 2023 International Congress

    Impulse control disorder related to dopaminergic therapy in progressive supranuclear palsy

    T. Thammongkolchai, P. Termsarasab (Bangkok, Thailand)

    Objective: To report a patient with progressive supranuclear palsy (PSP) in whom an impulse control disorder (ICD) was triggered by a dopaminergic therapy. Background: ICDs…
  • 2023 International Congress

    Clinical and radiological characteristics of a cohort of seventy-one Multiple System Atrophy patients

    G. Franco, G. Lazzeri, E. Bernardi, F. Arienti, A. Di Fonzo (Milan, Italy)

    Objective: This study aimed to review the characteristics of large cohort of MSA patients diagnosis in our center, confirming previous clinical and imaging data from…
  • 2023 International Congress

    Development of potent, orally bioavailable, and highly selective LRRK2 PROTAC® degrader molecules as potential disease modifying therapeutics for Parkinson’s disease

    K. Kelly, J. Meredith, L. Kimmel, S. Sparks, A. Desantis, D. Bryce, R. Wilson, J. Corradi, S. Keenan, G. Cadelina, J. Pizzano, A. Cacace (New Haven, USA)

    Objective: Report on the pharmacological characteristics of small molecule PROteolysis TArgeting Chimera (PROTAC) molecules designed to induce degradation of leucine rich repeat kinase 2 (LRRK2)…
  • 2023 International Congress

    Phenotypic presentation of essential tremor patients with Rapid eye movement disorder

    A. Rekik, A. Nasri, S. Mrabet, A. Atrous, A. Souissi, A. Gharbi, I. Kacem, A. Gargouri, R. Gouider (Tunis, Tunisia)

    Objective: To describe the prevalence of rapid eye movement disorder (RBD) among essential tremor (ET) patients and its correlates in terms of associated motor and…
  • « Previous Page
  • 1
  • …
  • 327
  • 328
  • 329
  • 330
  • 331
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley